Ekso Bionics Set to Report Third Quarter 2024 Results
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO), a renowned leader in exoskeleton technology tailored for both medical and industrial purposes, has announced its plans to release financial and operational results for the third quarter of 2024.
Details of the Financial Release
The financial results will be disclosed after trading concludes on a specified Monday in October. Following this announcement, the management team will host a conference call where they will discuss the outcomes, providing insights into recent advancements and the company's trajectory.
Investors Are Encouraged to Participate
A live webcast of this significant event will be available in the 'Investors' section of the Ekso Bionics website. For those interested in listening to the conference call, dedicated phone lines are provided for both domestic and international callers.
Understanding the Call's Importance
This conference call represents an essential opportunity for investors and stakeholders to gain a deeper understanding of Ekso Bionics' performance and future initiatives. Insights garnered during the call can guide investment decisions and foster a connection with the company’s strategic vision.
Company Overview of Ekso Bionics
Founded in 2005, Ekso Bionics specializes in creating advanced exoskeleton solutions designed to amplify human capabilities in various settings. Their innovative technologies span from assisting individuals with mobility impairments to enhancing workforce capabilities across diverse industries.
Commitment to Innovation and Performance
Headquartered in the San Francisco Bay Area, Ekso Bionics continues to push the boundaries of technology. The company's commitment to developing cutting-edge wearable robots can be seen in their extensive research and product offerings. This dedication positions them as a frontrunner in the exoskeleton sector.
Connecting with Ekso Bionics
As the company gears up for its upcoming results announcement, it remains committed to an open dialogue with stakeholders. Ekso Bionics understands the importance of transparency and aims to keep its investors well-informed regarding any developments that impact the company.
Contact Information for Investors
For inquiries and more information, investors can reach out to David Carey at 212-867-1768. Additionally, they can make use of email communication for detailed discussions related to investments, ensuring all queries are addressed promptly.
Frequently Asked Questions
When will Ekso Bionics report its financial results?
Ekso Bionics will announce its third quarter financial results after market close on a specific date in October 2024.
How can I listen to the conference call?
Participants can join the conference call by dialing the provided numbers or through the live webcast on the Ekso Bionics website.
What is the focus of the upcoming call?
The call will cover financial results, recent developments, and future strategies for Ekso Bionics.
Where is Ekso Bionics based?
Ekso Bionics is headquartered in the San Francisco Bay Area, California.
Who should I contact for investor inquiries?
Investors can contact David Carey at 212-867-1768 for any inquiries related to their interests.